Daniel M. Schmitt

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Fort Worth, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Paul Lytle, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel M. Schmitt

Form 4 holding President, CEO and Director, Director

ACTUATE THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
564,071
Estimated value
$863,028
Report date
14 Aug 2026
Price
$1.53
Ownership
By The Schmitt Family Irrevocable Trust, dated December 31, 2019
Form 4 holding President, CEO and Director, Director

ACTUATE THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
22,223
Estimated value
$34,001
Report date
14 Aug 2026
Price
$1.53
Ownership
By The Andrew Schmitt Irrevocable Trust, dated December 31, 2019
Form 4 holding President, CEO and Director, Director

ACTUATE THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
22,223
Estimated value
$34,001
Report date
14 Aug 2026
Price
$1.53
Ownership
By The Anna Schmitt Irrevocable Trust, dated December 31, 2019
Form 4 holding President, CEO and Director, Director

ACTUATE THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
22,223
Estimated value
$34,001
Report date
14 Aug 2026
Price
$1.53
Ownership
By The Edward Schmitt Irrevocable Trust, dated December 31, 2019
Form 4 holding President, CEO and Director, Director

ACTUATE THERAPEUTICS, INC.

Security class
Employee Stock Option (right to buy)
Shares / value
237,000
Estimated value
Report date
01 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Director, Director

ACTUATE THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
14 Aug 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Daniel M. Schmitt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .